Augmedix — Investor Presentation (May 2023)
18 slides from Augmedix's investor presentation, May 12, 2023
Slide 1: Investor Presentation May 2023
Investor Presentation 1 May 2023
Slide 2: Forward-looking statements
This presentation includes forward - looking statements. All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding the Company’s future financial position, business strategy and plans and objectives of management for future ope
Slide 3: The Healthcare Dilemma
3 The Healthcare Dilemma 3 Clinician burnout and chronic staffing shortages are creating a significant gap between health systems’ capacity to provide care and the demand for care from a growing and aging patient population. Today’s point - of - care delivery policies and technologies consume up to
Slide 4: Augmedix Mission & Vision
Augmedix Mission & Vision 4 Our mission is to help healthcare providers shrink their care gap and increase patient access at scale by unburdening their clinicians from medical documentation so they can redirect more of their time towards patient care. We manage medical documentation virtually and un
Slide 5: Augmedix Benefits
5 5 Augmedix Benefits Save up to 3 hours per day Boost productivity by as much as 20% 40% improved work - life satisfaction 5
Slide 6: Augmedix at a Glance
38% YoY Real - time and asynchronous virtual medical documentation for clinicians Connect clinicians with Augmedix Notebuilder Platform through mobile devices and proprietary software Comprehensive and flexible solution capable of being delivered at scale to ~ 295,000 addressable clinicians Let clin
Slide 7: Augmedix Eases the EHR Burden on Providers & Creates System Efficiencies
Augmedix Eases the EHR Burden on Providers & Creates System Efficiencies Natural Conversation Enhanced Documentation Clinician - Patient Notebuilder Platform Electronic Health Record Medical documentation uploaded for clinician’s sign - off Natural Language Processing (NLP) and Large Language Models
Slide 8: Driving a $6 Billion Market Opportunity for Augmedix
8 Driving a $6 Billion Market Opportunity for Augmedix ~295,000 ¹ Addressable Clinicians in U.S. $6B U.S. Market Opportunity >57,000 ¹ Addressable Clinicians $1.2B+ Expansion Opportunity within Existing Customers United States India Bangladesh Sri Lanka Opportunity (1) Company estimates out of a tot
Slide 9: Augmedix Has the Broadest Product Portfolio
9 Augmedix Has the Broadest Product Portfolio Chart prep Prior to start of day RPA AI - powered $ Ambient Documentation Products Draft medical note TAT minutes AI - powered $ Quality - assured medical note TAT 4 hrs AI - powered + Augmedix quality control $$ Asynchronous Synchronous Quality - assure
Slide 10: Well Positioned within Documentation Market
10 Well Positioned within Documentation Market Dictation/Transcription Asynchronous Documentation Synchronous Documentation Pric e Low SA DAX DAX Express Dragon Fluency Direct Clinician Burden Remote In - Person Remote High Ambient Products Complete Note / Human in the Loop Draft Note / Pure AI
Slide 11: AI / ML Note automation is ultimate goal
AI / ML Note automation is ultimate goal Lower cost Scalable Standardization Rapid turn - around LLMs alone insufficient: • Encounters rarely follow note format - typically non - linear • Complex conditions often result in errors and “note” bloat • Need to convert conversational language into approp
Slide 12: Notebuilder Platform Drives Efficiency
12 Ambient conversation Messages Reminders Medical Note Chart Prep Coding ASR+ EHR Integration Augmedix NLP / LLMs Note Engine Builder Manager Building Block approach combines: • automated speech recognition • natural language processing and large language models • Clinical datasets 35+ Specialties
Slide 13: Quality Assured Ambient Conversation to Note Creation
13 Quality Assured Ambient Conversation Clinician - Patient Transparent Note Creation Notebuilder Canvas Automatic Speech Recognition (ASR) Clinician : Nice to meet you . What brings you in today? Patient: I got a headache yesterday and it just won’t go away. Clinician: Any fever or chills? Patient:
Slide 14: Competitive Differentiation
14 Transparency User control Structured data Product fungibility Broad care settings Competitive Differentiation
Slide 15: Robust KPI Performance
15 Robust KPI Performance NRR (1) 125% (2) 43% YoY CIS Growth 41% 43% 49% 53% 1. Based on current period revenue including any expansion or new services and is net of contraction or churn compared to the previous period one year ago, but excludes revenue from new Health Enterprises for the current p
Slide 16: Consistent Strong Growth
16 Consistent Strong Growth $12M strategic financing, including HCA Healthcare, enables Augmedix to reach cash flow breakeven exiting Q4 2024 Note: Fiscal years are audited through December 31, 2022. Quarterly results are unaudited. (1) Q2 2021 includes one - time benefit from a previous office leas
Slide 17: Highly Experienced Management Team
Highly Experienced Management Team Sandra Breber Chief Operating Officer Paul Ginocchio Chief Financial Officer Rashed Noman Country Manager, Bangladesh Ian Shakil Co - Founder & Chief Strategy Officer Jonathan Hawkins Chief Revenue Officer Davin Lundquist Chief Medical Officer Saurav Chatterjee Chi
Slide 18: Investment Highlights
Investment Highlights Broad virtual documentation offerings that are differentiated and flexible across a variety of care settings Increases clinician productivity, optimizes reimbursement and improves patient access Deployed at 5 of top 10 US healthcare enterprises with high Net Revenue Retention A